The 61st annual meeting of the American Society of Hematology (ASH) will take place in Orlando, Florida, December 7 - 10, 2019.
More than 30 physicians, researchers, and students from Winship Cancer Institute of Emory University (Winship), including Winship members in the Aflac Cancer and Blood Disorders Center, will be presenting at the 61st annual meeting of the American Society of Hematology (ASH), which will take place in Orlando, Florida, December 7 - 10, 2019.
Among the Winship investigators making oral presentations are: Pamela Allen, MD, presenting on results from a Phase II study she led investigating the impact of pembrolizumab monotherapy in previously untreated patients with classical Hodgkin lymphoma; Benjamin Barwick, PhD, on how epigenetic programming may contribute to multiple myeloma pathogenesis; and Jonathan Kaufman, MD, on a Phase I/II study evaluating the safety and efficacy of a combination therapy for patients with relapsed/refractory multiple myeloma. Kaufman will also be leading two education programs during the conference on how to treat high-risk myeloma patients.
Sagar Lonial, MD, Winship chief medical officer and chair of Emory's Department of Hematology and Medical Oncology, will speak at the Friday night symposia on the topic of common practical issues encountered by clinicians managing patients with multiple myeloma.
Winship investigators in the Emory Department of Pediatrics and Aflac Cancer and Blood Disorders Center include Soumitri Sil, PhD; Shannon Meeks, MD; Tamara Miller, MD; Yongzhi Qiu, PhD; and Wilbur Lam, MD, PhD, who is also a researcher with the Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
"Winship will be represented at this year's ASH meeting by a breadth of scholarship and clinical expertise," says Lonial. "Winship investigators continue to excel at multidisciplinary collaboration to break ground in scientific, translational and clinical research." In addition to oral presentations, Winship faculty will be moderating many sessions, and there are over 20 poster presentations featuring work from the lab or clinic on outcomes for hematology.
Hematologists representing the full continuum of Winship's dedication to cancer education will be presenting at ASH, including James Eckman, MD, professor emeritus, who is giving a special-interest session on acute care treatment models beyond infusion centers; and Esther Kim, a senior at Lanier High School and one of the students who participated in Winship's Summer Scholars Research Program this year. Kim is attending the conference to present a poster on risk factors for bacteremia and subsequent mortality in patients with cutaneous T-cell lymphoma.
The 8th Annual BMT Winter Workshop co-chaired by Winship's Edmund K. Walter, MD, PhD, will take place in Orlando on the Friday night before the ASH conference begins.
